Pelthos Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	14.2	0.51	0.1	0.06	-	-
Cash & Short-Term Investments	14.2	0.51	0.1	0.06	-	-
Cash Growth	1031.80%	432.67%	75.02%	-	-	-
Prepaid Expenses	3.42	0.07	-	-	-	-
Other Current Assets	-	0.79	-	-	-	0.07
Total Current Assets	49.76	1.37	0.1	0.06	-	0.07
Total Assets	126.43	1.37	0.1	0.06	-	0.07
Accounts Payable	5.67	1.9	4.62	2.99	2.58	3.41
Accrued Expenses	11.89	-	0.65	0.22	-	-
Short-Term Debt	-	2.19	1.27	0.54	-	0.24
Other Current Liabilities	5.56	-	0.01	0.01	-	-
Total Current Liabilities	24.77	4.08	6.54	3.76	2.58	3.65
Long-Term Debt	-	-	-	-	1.1	-
Total Liabilities	68.18	4.08	6.54	3.76	3.68	3.65
Common Stock	-	0	0	0	-	-3.58
Additional Paid-In Capital	101.38	18.76	7.07	2.43	-	-
Retained Earnings	-43.13	-21.47	-13.52	-6.14	-3.68	-
Total Common Equity	58.25	-2.71	-6.44	-3.71	-3.68	-3.58
Shareholders' Equity	58.25	-2.71	-6.44	-3.71	-3.68	-3.58
Total Liabilities & Equity	126.43	1.37	0.1	0.06	-	0.07
Total Debt	3.48	2.19	1.27	0.54	1.1	0.24
Net Cash (Debt)	10.72	-1.67	-1.17	-0.49	-1.1	-0.24
Net Cash Per Share	8.67	-3.00	-9.18	-11.15	-	-
Filing Date Shares Outstanding	3.06	0.61	0.59	0.11	-	-
Total Common Shares Outstanding	3.09	0.61	0.39	0.11	-	-
Working Capital	24.99	-2.71	-6.44	-3.71	-2.58	-3.58
Book Value Per Share	18.85	-4.45	-16.46	-33.36	-	-
Tangible Book Value	-4.89	-2.71	-6.44	-3.71	-3.68	-3.58
Tangible Book Value Per Share	-1.58	-4.45	-16.46	-33.36	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q